Park Medi World IPO
The Park Medi World Ltd IPO, from one of North India’s leading private hospital chains, is currently open for public subscription. Investors and traders are closely watching the grey market premium (GMP) and subscription figures to gauge demand and expected listing performance.
IPO Overview
- Company: Park Medi World Ltd. (Park Hospital chain)
- IPO Open Date: December 10, 2025
- IPO Close Date: December 12, 2025
- Price Band: ₹154 – ₹162 per share
- Lot Size: 92 shares
- Issue Size: Around ₹920 crore
- Allotment Date: December 15, 2025
- Listing Date: December 17, 2025 on BSE & NSE
The issue comprises a fresh issue of shares (approx ₹770 crore) and an offer for sale (OFS) of shares by existing shareholders.
Grey Market Premium (GMP)
Grey Market Premium (GMP) is an unofficial indicator of IPO listing expectations — showing how much more (or less) investors are willing to pay ahead of the official listing.
- GMP stands around ₹14 per share in the grey market.
- This suggests a potential listing price of about ₹172–₹176, roughly 7–9% above the IPO upper price band of ₹162.
- Earlier whispers had seen GMP as high as ₹30+ before the issue opened, but it has cooled recently.
Important: GMP is not official exchange data and can change rapidly based on demand, market mood, and subscription numbers. It should be used as an indicator, not a guarantee.
Subscription Status
As the IPO enters its final day:
- Overall subscription is still below full coverage (under 1x as of midday), indicating subdued demand relative to shares on offer.
- Non-Institutional and Retail categories have been stronger than Institutional bids, but overall participation hasn’t surged yet.
This may be a reason why the GMP has moderated, with investors cautious on valuation and broader market conditions.
What This Means for Investors
- Expectations of a listing “pop” — GMP reflects what grey market participants think the stock will list at compared to the ₹154–₹162 IPO band.
- A positive GMP (above ₹0) generally suggests anticipated listing gains.
Interpretation Today
- A current GMP of ₹14 (~8–9% premium) suggests modest listing expectations rather than aggressive gains seen in very hot IPOs.
- Since subscription rates are still moderate, final GMP and listing performance may shift right up through listing day.
Risks & Considerations
- GMP can be volatile and isn’t traded on formal exchanges — treat it cautiously.
- Fundamental company review, growth outlook, healthcare sector dynamics, and long-term profitability should also guide investment decisions — not just GMP.
How to Apply & Final Thoughts
If you’re thinking of applying:
- You can place bids through your brokerage/ASBA channels before the final deadline.
- Retail investors often use GMP as one of several tools to assess listing potential, but financials and sector prospects matter for long-term investing.
Healthcare continues to be a fast-growing sector in India, with increasing demand for quality private hospital care — a potential strategic reason behind interest in the Park Medi World IPO.